{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P31025",
      "entity_text" : "TLC",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:24424",
      "entity_text" : "zinc sulfate",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Oral zinc sulfate has also been evaluated as a second-line systemic treatment option for mild to moderate acne; 220 mg of zinc sulfate dosed three times daily produced a moderate TLC reduction (45.5% at 12 weeks) [XREF_BIBR].",
  "reading_complete" : "2020-08-04T11:16:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:03:40Z",
  "trigger" : "produced",
  "evidence" : [ "zinc sulfate dosed three times daily produced a moderate TLC" ],
  "pmc_id" : "5120627",
  "score" : 0
}